Long‐Term Oncologic Outcomes After Laparoscopic Radical Nephroureterectomy: A Contemporary Analysis From a Japanese Multicenter Cohort

Read full text
Authors: Toru Kanno, Ryoichi Saito, Yuki Kita, Takeshi Sano, Shigeki Koterazawa, Toshifumi Takahashi, Yuto Hattori, Go Kobori, Tomohiro Fukui, Toshiya Akao, Shotaro Hatano, Takayuki Sumiyoshi
+3 more Kimihiko Masui, Takayuki Goto, Takashi Kobayashi
Cited by: 1
References: 14

Abstract

OBJECTIVES: To evaluate long-term oncologic outcomes and recurrence patterns after laparoscopic radical nephroureterectomy (LRNU) performed more than five years earlier. PATIENTS AND METHODS: We retrospectively analyzed patients who underwent LRNU before 2020 at nine Japanese institutions. Nonurothelial recurrence-free survival (RFS), cancer-specific survival (CSS), and overall survival (OS) were estimated using the Kaplan-Meier method. Cox proportional hazard models were applied to identify prognostic factors. Initial recurrence sites were assessed, with particular focus on disseminated recurrence. RESULTS: A total of 1102 patients were included, with a median follow-up of 57 months. Clinically locally advanced disease was observed in 212 patients (19%), including 178 (16%) with cT3-4 tumors and 64 (6%) with cN-positive disease. Lymphadenectomy was performed in 557 cases (51%). The 5-year RFS rates for pT < 1, pT1, pT2, pT3, and pT4 were 92%, 87%, 70%, 48%, and 20%, respectively. The corresponding CSS rates were 96%, 94%, 81%, 61%, and 21%, and the corresponding OS rates were 84%, 78%, 71%, 53%, and 15%. Older age at surgery and advanced pathological features were independent predictors of poorer RFS, CSS, and OS. Regarding recurrence patterns, distant recurrence occurred in 203 patients (18%), local recurrence in 127 (11%), and urothelial recurrence in 489 (45%). Disseminated recurrence was rare, occurring in 25 patients (2%), including 18 with retroperitoneal carcinomatosis and 3 (0.3%) with port-site recurrence. CONCLUSIONS: Our findings suggest that LRNU provides favorable long-term oncologic outcomes with low disseminated recurrence rates, appearing comparable to historical outcomes of open surgery.

Fields of Study & Subjects

Bladder and Urothelial Cancer Treatments Renal cell carcinoma treatment Multiple and Secondary Primary Cancers

Publication details

Journal / source
International Journal of Urology
Publisher
Wiley
Volume
33
Issue
7
Pages
e70566–e70566
Publication date
1 July 2026
Language
EN